BioSpace News Archive

President Trump’s new trade deal, now called the U.S.-Mexico-Canada Agreement, is wending its way before Congress. With that, the details are coming to light, and many critics of the biopharmaceutical industry and generic drug policy aren’t happy.

Most of the IPOs that occurred in the Bay State have been well-documented by BioSpace. But, with a new calendar year upon us, it’s a good idea to look back at a banner year of capitalization that may not repeat when January rolls around. With the turn of the year only days away, BioSpace takes a look at some of the key Massachusetts-based IPOs.

Boston-based Emulate focuses on developing true-to-life biological models, sometimes dubbed organs-on-chips. Emulate’s proprietary Organ-Chips include lung, liver, brain, intestine and kidney, are made up of minuscule hollow channels lined with thousands of living human cells and tissue, all about the size of an AA battery.

For 30 years, BioSpace Hotbed maps have been a guiding light for life science professionals. The original, watercolor artistry of the maps adorn offices around the country and also offer an at-a-glance reference to the industry’s leading innovators and employers.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them, from Northwestern, UC Davis, Cornell, Duke, and others.

The Narcan maker licensed a potential treatment for overdoses associated with synthetic marijuana, such as Spice and K2.

The vaccine, Vaxelis, was approved to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenza type b.

Horizon Pharma plc today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for RAVICTI® (glycerol phenylbutyrate) Oral Liquid to include infants younger than two months of age living with a urea cycle disorder (UCD).

Subject to NMPA acceptance, Bio-Thera Solutions plans to initiate the Phase I clinical trial early in 2019.

Ready to kickstart your health? The Physicians Committee for Responsible Medicine has the tools you need to get started in the relaunched 21-Day Vegan Kickstart online program and mobile app.